Table:
begin	end	state
1	25	cytoplasmic
26	44	transmembrane
45	63	non-cytoplasmic
64	83	transmembrane
84	93	cytoplasmic
94	114	transmembrane
115	119	non-cytoplasmic
120	138	transmembrane
139	158	cytoplasmic
159	182	transmembrane
183	187	non-cytoplasmic
188	207	transmembrane
208	253	cytoplasmic
254	273	transmembrane
274	292	non-cytoplasmic
293	311	transmembrane
312	322	cytoplasmic
323	341	transmembrane
342	351	non-cytoplasmic
352	373	transmembrane
374	382	cytoplasmic
383	404	transmembrane
405	415	non-cytoplasmic
416	436	transmembrane
437	449	cytoplasmic

Input:
>Pf6N2E2_4466 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_4466
MFAFFRPAAHQASLPEEKIDSTYRRLRWQIFAGIFIGYAGYYLLRKNFSLAMPYLIDEGY
TRGQLGLAMSAIAIAYGLSKFLMGLVSDRSNPRYFLPFGLLVSAGVMFVFGFAPWATSSV
TMMFILLFINGWAQGMGWPPSGRTMVHWWSQKERGGVVSVWNVAHNVGGGLIGPLFLLGM
GWFNDWHAAFYVPAAVALAVAVFAFVTMRDTPQSVGLPPIEKYKNDYPEGYDASHENEFS
AKEIFVKYVLRNKMLWYIAMANVFVYLLRYGVLDWAPTYLKEAKGFTVDKSSWAYFFYEW
AGIPGTLLCGWMSDKIFRGNRGLTGMVFMALVTVATLVYWLNPAGNPTVDMIALVSIGFL
IYGPVMLIGLQALELAPKKAAGTAAGFTGLFGYLGGSVAASAAMGYTVDHFGWDGGFVLL
IGACLMAMAFLAPTLWHKQIASQSREAVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server